Elan increases sales by 19%:
This article was originally published in Clinica
Executive Summary
Turnover at drug delivery company Elan has grown 19% to I£141.7 million ($223 million) in the 12 months to March. Net income rose 35% to I£56.4 million. Based in Dublin, Ireland, Elan expects its pending stock swap acquisition of Athena Neurosciences to close by the end of June (Clinica No 698, p 1).